A batch can finish manufacturing on schedule and still wait days for disposition. Missing attachments, repeated corrections, unclear ownership, and late laboratory results can turn record review into a hidden production constraint. A GMP batch record review assessment helps operations and quality leaders separate necessary review from avoidable waiting.
The goal is not faster approval at any cost. It is a complete, accurate review package and a reliable path to an authorized quality decision.
Start with the release requirements
For finished pharmaceuticals subject to 21 CFR 211.192, the quality control unit must approve production and control documentation before release or distribution. The rule also requires thorough investigation of unexplained discrepancies and specification failures, with documented conclusions and followup.
Improvement work must preserve those controls. Do not treat an unresolved investigation as a paperwork obstacle or let a shipping commitment determine the quality decision. Confirm the requirements that apply to your product; API and other product categories may follow different frameworks.
Map the complete review path
Select a representative group of recent batches, including routine batches and those with delays. Record when manufacturing ended, when the package was submitted, when review began, when questions were returned, and when disposition occurred. Include laboratory results and linked investigations rather than measuring only time spent in the quality department.
- Active review: Time spent checking records and supporting evidence.
- Queue time: Time waiting for an available reviewer or a required input.
- Correction time: Time resolving incomplete entries, missing evidence, or reviewer questions.
- Dependency time: Time awaiting testing, investigation conclusions, or another required approval.
A single batch may have overlapping delays. Avoid adding overlapping intervals twice. Use the same start and end definitions across departments so the baseline is meaningful.
Find the recurring causes of rework
Group review comments by cause rather than counting every comment as equivalent. Distinguish documentation mistakes from potential product quality concerns. Look for unclear instructions, inconsistent calculations, missing equipment records, incomplete reconciliation, and handoffs that rely on personal reminders.
Then ask where each issue could have been prevented. A clearer controlled instruction may help more than another reminder email. A completeness check at the end of a shift may prevent a missing attachment from being discovered several days later. Any process or document changes should follow the site’s approved controls.
Set a clear handoff standard
Define what makes a package ready for review. The standard should identify required records, supporting results, linked event references, responsible owners, and the route for resolving questions. It should not conceal open issues or substitute a checklist for technical judgment.
Agree how reviewers communicate questions and how operations responds. A shared issue log can reduce duplicate requests, but it must not replace controlled GMP records. Preserve traceability and use approved systems for official decisions and corrections.
Measure flow without rewarding shortcuts
Track median completion-to-disposition time, the oldest waiting package, the share accepted as complete at first submission, and recurring correction categories. Review these alongside investigation quality and documentation compliance. These are suggested operating measures, not regulatory release criteria.
As an illustrative example, if ten packages arrive each week but only eight leave the review process, the queue grows by two weekly. Check both arrival volume and sustainable review capacity before promising recovery dates. Adding reviewers alone will not fix incomplete submissions.
Turn the assessment into an action plan
Assign owners, due dates, required evidence, and effectiveness checks to the highest priority causes. Pilot changes on a defined product or workflow before expanding them. FDA’s ICH Q10 guidance provides a broader quality system model; the workflow measures above are practical suggestions, not additional FDA mandates.
PharmExcel’s manufacturing operations consulting services include reviewing production flow and quality handoffs. If completed batches keep waiting, contact Rob Braddock to discuss an assessment with a documented baseline, identified constraints, and a prioritized improvement plan.